Loss of cyclin‐dependent kinase‐like 2 predicts poor prognosis in gastric cancer, and its overexpression suppresses cells growth and invasion

Cyclin‐dependent kinase‐like 2 (CDKL2), a new member of the cyclin‐dependent kinase family, may be involved in gastric cancer (GC) progression. Thus, we conducted this study to explore the clinical effect of CDKL2 in GC. Immunohistochemistry was used to measure CDKL2 levels in gastric tissues. The a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Chia‐Lang, Uen, Yih‐Huei, Chen, Han‐Kun, Hseu, You‐Cheng, Lin, Chih‐Chan, Hung, Shih‐Ting, Sun, Ding‐Ping, Lin, Kai‐Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051174/
https://www.ncbi.nlm.nih.gov/pubmed/29790675
http://dx.doi.org/10.1002/cam4.1577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051174/
https://www.ncbi.nlm.nih.gov/pubmed/29790675
http://dx.doi.org/10.1002/cam4.1577

Ejemplares similares